Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ottinger

Showing results (521-530 of 535) with videos related to

Pageof 54
Sort By:
The Lancet. Oncology|August 22, 2009
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trialJürgen Finke, Wolfgang A Bethge, Claudia Schmoor, et al.
Journal of Virology|May 30, 2008
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine designNancy Gasper-Smith, Deanna M Crossman, John F Whitesides, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2018
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromeFrancis Ayuk, Dietrich W Beelen, Martin Bornhäuser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2009
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseMarc Nicolino, Barry Byrne, J Edmund Wraith, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
JCI Insight|March 13, 2020
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityUgur Eskiocak, Wilson Guzman, Benjamin Wolf, et al.
Current Topics in Medicinal Chemistry|November 29, 2013
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseElizabeth A Ottinger, Mark L Kao, Nuria Carrillo-Carrasco, et al.
International Journal of Cancer|March 8, 2021
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysisDaniel Buergy, Florian Würschmidt, Eleni Gkika, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
The Science of the Total Environment|November 10, 2020
A multi-taxonomic framework for assessing relative petrochemical vulnerability of marine biodiversity in the Gulf of MexicoBeth Polidoro, Cole W Matson, Mary Ann Ottinger, et al.
Pageof 54

Showing results (521-530 of 535) with videos related to

Sort By:
Pageof 54
The Lancet. Oncology|August 22, 2009
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trialJürgen Finke, Wolfgang A Bethge, Claudia Schmoor, et al.
Journal of Virology|May 30, 2008
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine designNancy Gasper-Smith, Deanna M Crossman, John F Whitesides, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2018
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromeFrancis Ayuk, Dietrich W Beelen, Martin Bornhäuser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2009
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseMarc Nicolino, Barry Byrne, J Edmund Wraith, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
JCI Insight|March 13, 2020
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicityUgur Eskiocak, Wilson Guzman, Benjamin Wolf, et al.
Current Topics in Medicinal Chemistry|November 29, 2013
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseElizabeth A Ottinger, Mark L Kao, Nuria Carrillo-Carrasco, et al.
International Journal of Cancer|March 8, 2021
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysisDaniel Buergy, Florian Würschmidt, Eleni Gkika, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
The Science of the Total Environment|November 10, 2020
A multi-taxonomic framework for assessing relative petrochemical vulnerability of marine biodiversity in the Gulf of MexicoBeth Polidoro, Cole W Matson, Mary Ann Ottinger, et al.
Pageof 54